Faye Pais, MD

Title(s)Resident Physician, Dean's Office
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    University of California San Francisco, Fresno2018  - 2019Chief Resident, Internal Medicine
    University of California San Francisco, Fresno2018Internal Medicine PGY3 Resident of the Year
    University of California San Francisco, Fresno2018Laennec Prize
    University of California San Francisco, Fresno2017Borba Research Award
    University of California San Francisco, Fresno2017Laennec Prize
    University of California San Francisco, Fresno2017Innovation and Quality Improvement Award

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    A Comparative Study of the Performance of Spirometry and Lung Volume Reversibility Indices and their Association with Serum Inflammatory Markers in Asthmatics and Age-Gender Matched Normal Controls
    David & Marilyn Britz Lung Disease Research Award on Residual Volume Reversibility in Asthma (REVOREA) May 12, 2018 - May 11, 2020
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pais FM, Shah RA, Vempilly JJ, Gullapalli S, Upadhyay D, Peterson M, Liberman M, Hegde P.Transesophageal approach to lung, adrenal biopsy and fiducial placement using Endoscopic UltraSonography (EUS): An interventional pulmonology experience. Initial experience of the FRETOC (Fresno Tracheobronchial & Oesophageal Center) study group. Respiratory Medicine. 2018; 141(1):52-55.
    2. Pais FM, Sinha P, Liu KD, Matthay MA. Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials. Respir Care. 2018 08; 63(8):1060-1069. PMID: 29991643.
      View in: PubMed
    3. Pais F, Fayed M, Evans T. Lymphangioleiomyomatosis: an explosive presentation of a rare disease. Oxf Med Case Reports. 2017 Jun; 2017(6):omx023. PMID: 28616248.
      View in: PubMed
    4. Pais F, Fayed M, Evans T.The successful use of extracorporeal membrane oxygenation in systemic lupus erythematosus-induced diffuse alveolar haemorrhage. European Journal of Case Reports in Internal Medicine. 2017; 4(1):2016_000515.
    5. Jones CL, Gearheart CM, Fosmire S, Delgado-Martin C, Evensen NA, Bride K, Waanders AJ, Pais F, Wang J, Bhatla T, Bitterman DS, de Rijk SR, Bourgeois W, Dandekar S, Park E, Burleson TM, Madhusoodhan PP, Teachey DT, Raetz EA, Hermiston ML, Müschen M, Loh ML, Hunger SP, Zhang J, Garabedian MJ, Porter CC, Carroll WL. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. Blood. 2015 Nov 05; 126(19):2202-12. PMID: 26324703.
      View in: PubMed
    6. Dandekar S, Romanos-Sirakis E, Pais F, Bhatla T, Jones C, Bourgeois W, Hunger SP, Raetz EA, Hermiston ML, Dasgupta R, Morrison DJ, Carroll WL. Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia. Br J Haematol. 2014 Oct; 167(1):87-99. PMID: 24995804; PMCID: PMC4207443.